Related Experiment Video
Updated: Jan 14, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Gaps and Disparities in Celiac Disease Screening: A Nationwide Analysis of a High-Risk Pediatric Population
Erin B P Miller1, Kate Avery1, Amy Ratner1
1Beyond Celiac, Ambler, PA, USA.
Insights
Celiac disease (CeD) screening adherence is low in children with high-risk conditions, with only 10% screened. Non-White and younger children face significant disparities in CeD screening.
Area of Science:
- Pediatric gastroenterology
- Public health screening initiatives
- Autoimmune disease epidemiology
Background:
- Celiac disease (CeD) screening guidelines exist for high-risk pediatric populations.
- Undiagnosed CeD can lead to severe long-term health issues.
- Current screening adherence among eligible children remains unclear.
Purpose of the Study:
- To evaluate adherence to celiac disease (CeD) screening guidelines in children with high-risk conditions.
- To identify disparities in CeD screening based on age, race, and specific conditions.
Main Methods:
- Retrospective cohort analysis of US private payer claims data (2007-2022).
- Identified children (≤20 years) with high-risk conditions for CeD screening.
- Used descriptive statistics, chi-square tests, and logistic regression to analyze screening rates and associated factors.
Main Results:
- Only 10.0% of 223,449 eligible children were screened for CeD.
- Children with a family history of CeD had the highest screening rate (55.49%).
- Non-White children and those under 11 years were screened significantly less than White children and older peers, respectively. These disparities persisted in multivariable analysis.
Conclusions:
- Significant gaps exist in adhering to CeD screening guidelines for children.
- Younger and Non-White children experience notable under-screening.
- Improved awareness and implementation of CeD screening practices are crucial for high-risk pediatric groups.
Purpose:
Despite established screening guidelines for celiac disease (CeD) targeting high-risk groups, many people remain undiagnosed, leading to potential long-term health consequences. The aim of this study was to evaluate adherence to CeD screening guidelines among children with high-risk conditions.
Methods:
We performed a retrospective cohort analysis utilizing United States (US) private payer claims data from 2007 to 2022 to identify children ≤ 20 years who met screening criteria for CeD. All children had at least one high-risk condition recommended for CeD screening by professional organizations. Those with a history of CeD were excluded. We used descriptive statistics and chi-square tests to assess the presence of CeD screening by age group, race, and condition to determine the value of screening results by race. Logistic regression models were used to identify factors associated with CeD screening.
Results:
Among 223,449 children with high-risk conditions, only 10.0% were screened. Patients with a family history of CeD had the highest likelihood of being screened (55.49%). Non-White children were screened less frequently than White children (p < .0001), which held true when stratifying by most screening conditions. Children aged < 11 years were screened less frequently than their older peers (p < .0001). In a multivariable model, age and racial disparities in screening persisted.
Conclusion:
Our findings highlight significant gaps in adherence to CeD screening guidelines, particularly among younger and Non-White children, underscoring the need for improved awareness and implementation of screening practices.
More Related Videos
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
06:50A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Excretion
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Distribution